NEWS

Client News: Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program

Client News: Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program

Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi on the announcement of the first-ever application of click chemistry in humans, with the launch of the Company’s lead clinical candidate, SQ3370. Shasqi is the first Y Combinator-backed biotech company to reach clinical development.

read more
Agilex Biolabs Encourages Biotechs to Move Delayed Trials to Australia at BIO Digital 2020

Agilex Biolabs Encourages Biotechs to Move Delayed Trials to Australia at BIO Digital 2020

Adelaide, Australia – Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, encouraged biotechs to consider Australia for their clinical trials during a presentation at BIO Digital 2020.

Australia’s impressive COVID-19 management and the world’s most attractive rebate on clinical trials costs are just a few of the reasons that make it an ideal location to restart delayed trials, according to Agilex Biolabs.

read more
Transcript | Endpoints Webinar

Transcript | Endpoints Webinar

Arsalan Arif: All right. Hi everybody. I'm Arsalan Arif, the publisher of Endpoints News and I'm pleased to be your moderator today. Today's webinar is sponsored by Agilex Biolabs in Australia and our topic is the Australian Advantage, de-risk your early phase trials....

read more

Talk to us about your next project

We bring in our client services and scientific experts to offer you the best solutions
Contact UsOr book a call with us now